QingSong Health Sets 24 Aug 2026 Board Meeting to Approve 1H26 Results and Potential Interim Dividend

Bulletin Express08-12

QingSong Health Corporation has scheduled a board meeting for 24 August 2026. Directors will review and approve the consolidated interim results for the six months ended 30 June 2026 and decide on the declaration of any interim dividend.

The board currently comprises two executive directors—Chairlady and CEO Yang Yin and Gao Yushi—one non-executive director, Wu Bin, and three independent non-executive directors: Dr. Wang Xiaoyan, Chow Yiu Ming and Ji Wenting.

The announcement was released in Hong Kong on 12 August 2026. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited accept no responsibility for its contents.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment